Back to Results
First PageMeta Content
Muscarinic antagonists / Respiratory therapy / Quaternary ammonium compounds / Alcohols / Phenols / Formoterol / Chronic obstructive pulmonary disease / Bronchodilator / Tiotropium bromide / Chemistry / Pulmonology / Organic chemistry


7.11 INDACATEROL WITH GLYCOPYRRONIUM (FDC), indacaterol 110 microgram + glycopyrronium 50 microgram, inhalation: powder for, 30 capsules, Ultibro® Breezhaler® 110/50, Novartis Pharmaceuticals Australia Pty Ltd
Add to Reading List

Open Document

File Size: 51,16 KB

Share Result on Facebook

Company

Novartis Pharmaceuticals Australia Pty Ltd / The PBAC / /

Country

Australia / /

Facility

University Family Medicines Research Centre / /

IndustryTerm

treatment of chronic obstructive pulmonary disease / inhaler devices / pharmaceutical benefit / combination product / devices / combination products / healthcare professional / treatment algorithm / /

MedicalCondition

COPD / chronic obstructive pulmonary disease / asthma / /

Organization

Streamlined Authority / Sydney University Family Medicines Research Centre / /

Position

Minister / nurse / General / /

Product

beta-2 / /

Technology

treatment algorithm / GPS / /

SocialTag